BCPC · Balchem Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $270.71M | - | $267.56M | $255.47M | $250.52M | - | $239.94M | $234.08M | $239.66M | - |
| Cost of Revenue | $169.63M | - | $172.10M | $162.35M | $162.35M | - | $154.58M | $151.09M | $158.15M | - |
| Gross Profit | $101.08M | - | $95.45M | $93.11M | $88.17M | - | $85.36M | $82.99M | $81.51M | - |
| R&D | $5.88M | - | $4.50M | $4.30M | $4.66M | - | $4.33M | $3.85M | $4.10M | - |
| SG&A | $18.48M | - | $17.29M | $18.07M | $15.56M | - | $17.48M | $15.33M | $17.51M | - |
| Total Operating Expenses | $45.46M | - | $40.87M | $41.67M | $37.15M | - | $37.37M | $37.20M | $39.84M | - |
| D&A | $12.49M | - | $11.55M | $11.40M | $11.01M | - | $10.90M | $12.51M | $13.67M | - |
| Operating Income | $55.63M | - | $54.58M | $51.44M | $51.02M | - | $47.99M | $45.80M | $41.68M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $12.24M | - | $11.76M | $10.73M | $10.89M | - | $10.06M | $9.16M | $7.86M | - |
| Net Income | $40.28M | - | $40.29M | $38.28M | $37.05M | - | $33.84M | $32.07M | $28.99M | - |
| EPS - Basic | $1.26 | - | $1.25 | $1.18 | $1.14 | - | $1.05 | $0.99 | $0.90 | - |
| EPS - Diluted | $1.25 | - | $1.24 | $1.17 | $1.13 | - | $1.03 | $0.98 | $0.89 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72.87M | $74.57M | $65.09M | $65.43M | $49.90M | $49.52M | $73.69M | $63.74M | $60.35M | $64.45M |
| Accounts Receivable | $154.23M | $143.60M | $131.54M | $135.98M | $130.45M | $119.66M | $120.54M | $123.40M | $139.88M | $125.28M |
| Inventory | $146.74M | $131.45M | $132.44M | $148.15M | $144.93M | $130.80M | $118.51M | $117.10M | $110.38M | $109.52M |
| Accounts Payable | $70.73M | $60.42M | $46.98M | $67.86M | $65.97M | $54.74M | $46.46M | $54.50M | $59.80M | $55.50M |
| Current Assets | $388.94M | $365.61M | $343.71M | $364.86M | $340.24M | $313.77M | $325.99M | $320.16M | $324.86M | $314.24M |
| Total Assets | $1.69B | $1.69B | $1.66B | $1.68B | $1.62B | $1.58B | $1.60B | $1.57B | $1.59B | $1.60B |
| Current Liabilities | $152.54M | $176.38M | $126.37M | $138.14M | $139.56M | $157.69M | $109.44M | $113.32M | $124.42M | $148.49M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $408.63M | $428.84M | $363.17M | $410.33M | $408.85M | $425.46M | $419.72M | $462.60M | $509.91M | $543.23M |
| Stockholders' Equity | $1.29B | $1.26B | $1.30B | $1.27B | $1.21B | $1.15B | $1.18B | $1.11B | $1.08B | $1.05B |
| Retained Earnings | $1.16B | $1.12B | $1.11B | $1.07B | $1.03B | $997.49M | $992.38M | $958.54M | $926.47M | $897.49M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $40.06M | - | - | - | $36.46M | - | - | - | $33.39M | - |
| Investing Cash Flow | ($6.29M) | - | - | - | ($5.91M) | - | - | - | ($6.74M) | - |
| Financing Cash Flow | ($34.78M) | - | - | - | ($31.97M) | - | - | - | ($30.02M) | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 37.3% | - | 35.7% | 36.4% | 35.2% | - | 35.6% | 35.5% | 34.0% | - |
| Operating margin | 20.5% | - | 20.4% | 20.1% | 20.4% | - | 20.0% | 19.6% | 17.4% | - |
| EBITDA margin | 25.2% | - | 24.7% | 24.6% | 24.8% | - | 24.5% | 24.9% | 23.1% | - |
| Net margin | 14.9% | - | 15.1% | 15.0% | 14.8% | - | 14.1% | 13.7% | 12.1% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | 2.2% | - | 1.7% | 1.7% | 1.9% | - | 1.8% | 1.6% | 1.7% | - |
| SG&A / Revenue | 6.8% | - | 6.5% | 7.1% | 6.2% | - | 7.3% | 6.5% | 7.3% | - |
| Effective tax rate | 23.3% | - | 22.6% | 21.9% | 22.7% | - | 22.9% | 22.2% | 21.3% | - |
| Return on assets | 2.4% | - | 2.4% | 2.3% | 2.3% | - | 2.1% | 2.0% | 1.8% | - |
| Return on equity | 3.1% | - | 3.1% | 3.0% | 3.1% | - | 2.9% | 2.9% | 2.7% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.55 | 2.07 | 2.72 | 2.64 | 2.44 | 1.99 | 2.98 | 2.83 | 2.61 | 2.12 |
| Quick ratio | 1.59 | 1.33 | 1.67 | 1.57 | 1.40 | 1.16 | 1.90 | 1.79 | 1.72 | 1.38 |
| Cash ratio | 0.48 | 0.42 | 0.52 | 0.47 | 0.36 | 0.31 | 0.67 | 0.56 | 0.49 | 0.43 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.32 | 1.34 | 1.28 | 1.32 | 1.34 | 1.37 | 1.36 | 1.42 | 1.47 | 1.52 |
| Liabilities / Assets | 0.24 | 0.25 | 0.22 | 0.24 | 0.25 | 0.27 | 0.26 | 0.29 | 0.32 | 0.34 |
| Efficiency | ||||||||||
| Asset turnover | 0.16 | - | 0.16 | 0.15 | 0.15 | - | 0.15 | 0.15 | 0.15 | - |
| Inventory turnover | 1.16 | - | 1.30 | 1.10 | 1.12 | - | 1.30 | 1.29 | 1.43 | - |
| Days sales outstanding | 208d | - | 179d | 194d | 190d | - | 183d | 192d | 213d | - |
| Days inventory outstanding | 316d | - | 281d | 333d | 326d | - | 280d | 283d | 255d | - |
| Days payable outstanding | 152d | - | 100d | 153d | 148d | - | 110d | 132d | 138d | - |
| Cash conversion cycle | 372d | - | 361d | 375d | 368d | - | 353d | 344d | 330d | - |
| Valuation | ||||||||||
| P / E | 135.6x | - | 121.0x | 136.1x | 146.9x | - | 170.9x | 157.1x | 174.1x | - |
| P / B | 4.3x | - | 3.8x | 4.1x | 4.5x | - | 4.9x | 4.5x | 4.7x | - |
| P / S | 20.2x | - | 18.3x | 20.4x | 21.7x | - | 24.0x | 21.5x | 21.1x | - |
| EV / EBITDA | 79.3x | - | 73.0x | 81.7x | 87.0x | - | 96.7x | 85.1x | 90.3x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 8.1% | - | 11.5% | 9.1% | 4.5% | - | 4.3% | 1.2% | 3.1% | - |
| Revenue CAGR (3y) | 5.2% | - | 3.1% | 2.6% | 3.1% | - | 6.6% | 5.0% | 8.9% | - |
| Revenue CAGR (5y) | 7.8% | - | 8.8% | 8.1% | 7.5% | - | 8.6% | 7.7% | 8.8% | - |
| Gross profit growth (YoY) | 14.6% | - | 11.8% | 12.2% | 8.2% | - | 11.5% | 7.3% | 11.4% | - |
| Operating income growth (YoY) | 9.0% | - | 13.7% | 12.3% | 22.4% | - | 10.0% | 6.9% | 21.1% | - |
| Net income growth (YoY) | 8.7% | - | 19.1% | 19.4% | 27.8% | - | 16.4% | 6.5% | 27.6% | - |
| EPS growth (YoY) | 10.6% | - | 20.4% | 19.4% | 27.0% | - | 14.4% | 5.4% | 27.1% | - |
| EPS CAGR (3y) | 21.3% | - | 16.7% | 8.3% | 8.3% | - | 10.2% | 11.9% | 7.3% | - |
| EPS CAGR (5y) | 11.7% | - | 13.4% | 12.5% | 13.1% | - | 10.0% | 9.9% | 8.9% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 6.3% | 9.3% | 10.2% | 14.0% | 12.0% | 9.1% | 14.8% | 10.5% | 10.8% | 12.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$1.03B totalHuman Nutrition And Health$659.39M · 63.9%
Animal Nutrition And Health$230.85M · 22.4%
Specialty Products$140.98M · 13.7%
Product / service
$1.04B totalProduct Sales$1.04B · 99.8%
Royalty$1.89M · 0.2%
Geographic
$1.04B totalUS$759.45M · 73.2%
Non Us$277.71M · 26.8%
Peer comparison
Same SIC group: Chemicals & Allied Products
Comparing BALCHEM CORP against the 5 most active filers in the same SIC group.
Dividends
$0.96/share trailing 12 months · +10.3% YoY
| Ex-date | Per share |
|---|---|
| Dec 23, 2025 | $0.9600 |
| Dec 26, 2024 | $0.8700 |
| Dec 26, 2023 | $0.7900 |
| Dec 23, 2022 | $0.7100 |
| Dec 27, 2021 | $0.6400 |
| Dec 24, 2020 | $0.5800 |
| Dec 27, 2019 | $0.5200 |
| Dec 24, 2018 | $0.4700 |
| Dec 26, 2017 | $0.4200 |
| Dec 22, 2016 | $0.3800 |
| Dec 23, 2015 | $0.3400 |
| Dec 24, 2014 | $0.3000 |
| Dec 19, 2013 | $0.2600 |
| Dec 12, 2012 | $0.2200 |
| Dec 12, 2011 | $0.1800 |
| Dec 17, 2010 | $0.1500 |
| Dec 28, 2009 | $0.0733 |
| Dec 18, 2008 | $0.0733 |
| Dec 18, 2007 | $0.0733 |
| Dec 27, 2006 | $0.0400 |
| Dec 28, 2005 | $0.0267 |
| Dec 28, 2004 | $0.0178 |
| Dec 24, 2003 | $0.0158 |
| Dec 23, 2002 | $0.0158 |